Home follow-up of early- and mid-stage Alzheimer's patients

G Taşdemır1, F Oz

  • 1Department of Nursing, Pamukkale University, Denizli School of Health, Denizli, Turkey. gtasdemir@gmail.com

The study is carried out as an action research to investigate the effect of nursing interventions during home visits to early- and mid-stage Alzheimer's patients problems and the anxiety and depression levels. The study was realized as one initial visit, six weekly visits and another visit 1 month later in 40 early- and mid-stage Alzheimer's patients who met the study criterion and accepted to join the study presenting at a Turkish university hospital. The data were collected using the Alzheimer's Patient Data Collection Form, Cornell Scale for Depression in Dementia and Spielberg's State-Trait Anxiety Inventory. We found a statistically significant decrease in patient problems compared to the initial with nursing interventions administered during home visits during the study (P < 0.05). However, the follow-up visit 1 month after the weekly visits did not show persistence of this decrease in problems and some problems were found to have increased. There was a statistically significant decrease in the mean depression and situational and continuous anxiety scores of the patients at the end of the follow-up compared to the initial period with the nursing interventions administered during the follow-ups (P < 0.05). According to these results, it is recommended that continuous programmes for home care should be developed for Alzheimer's patients in Turkey.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...